Drug Database · Clinicians

Dibasic + Monobasic

Brands (4) Colema, Fleet Enema (For Children), Lainema…Show all

US brand (reference label): Fleet; not a Philippine-registered brand.

Laxative/Cathartic; Cathartic PH FDA category
Fixed-dose combination.

Rx · Prescription drugOTC · Over-the-counter4 PH products
Dispensing: Over-the-counter (OTC) · Prescription (Rx) Last updated: Audience: Licensed health professionals
Label text on this page: US FDA-approved label via DailyMed/openFDA, set ID c1677d70-203b-493e-88f0-815a66133f1d, version date November 20, 2025 (Fleet · C.B. Fleet Company, Inc.). Reproduced verbatim. Philippine-approved indications and doses may differ: check the PH package insert.

Use: Labeled indications

  • Use for relief of occasional constipation.
US FDA label
Full indications and usage US FDA label

Use for relief of occasional constipation. This product usually produces a bowel movement in 1 to 5 minutes.

Dosing: Adult

Dosage and administration (US label) US FDA label

Directions Single Daily Dosage (per 24 hours) Do not use if taking another sodium phosphates product. Do not use more unless directed by a doctor. See Warnings. adults and children 12 years and over 1 bottle per day children 2 to 11 yearsuse Fleet® Pedia-Lax® Enema children under 2 yearsDO NOT USE If no urge is felt after 5 minutes of using, try to empty bowel. Call a doctor promptly if no liquid comes out of the rectum after 30 minutes because dehydration could occur.

Dosing: Altered kidney function

No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosage forms

Philippines

  • Rectal solution: 13.9 g/3.2 g per 100 mL, 19 g/7 g per 118 mL
  • Liquid enema: 9.5 g/3.5 g per 59 mL
  • Oral solution: 24.4 g/10.8 g per 45 mL

Registered products in the Philippines

4 products registered with the Food and Drug Administration (FDA) Philippines list Dibasic + Monobasic as the generic name (including products registered under a variant spelling). Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Also registered under: Monobasic Sodium Phosphate Monohydrate + Dibasic Sodium Phosphate Heptahydrate (1 product). Products registered under these spellings are included in the table and marked.

Verify on PH FDA portal

All registered products4
Philippine FDA-registered products for Dibasic + Monobasic
Package insert
ColemaMonobasic Sodium Phosphate Monohydrate + Dibasic Sodium Phosphate HeptahydrateVariant spelling
19 g/7 g per 118 mL Rectal SolutionPE Plastic Bottle with White Plastic Nozzle and Orange Outer Covering x 133 mL (Box of 1's)
Rx
Jewim Pharmaceutical (Shandong) Co., Ltd.China
Next Chemical Enterprises
DRP-6411
Aug 20, 2029
Fleet Enema (For Children)Monobasic Sodium Phosphate + Dibasic Sodium Phosphate
9.5 g/3.5 g per 59 mL Liquid EnemaLDPE Bottle x 66 mL Box of 1's
OTC
C.B. Fleet Company, IncorporatedUSA
Importer: Getz Bros. Philippines, Inc.
DR-XY21764
Jul 21, 2028
LainemaMonobasic Sodium Phosphate + Dibasic Sodium Phosphate
13.9 g/3.2 g per 100 mL Rectal SolutionLow Density Polyethylene (LDPE) Bottle x 140 mL (Box of 1's)
OTC
Lainco, SASpain
RiteMED Phils., Inc.
DRP-15153
May 15, 2029
Phospho-SodaMonobasic Sodium Phosphate + Dibasic Sodium Phosphate
24.4 g / 10.8 g per 45 mL Oral Solution (Ginger Lemon Flavor)HDPE bottle with PP screw cap x 45 mL (Box of 1’s)
Rx
Casen Recordati, S.L.Spain
Getz Bros. Philippines, Inc.
DR-XY48096
Jun 8, 2027

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Warnings/Precautions

Warnings and precautions (US label) US FDA label

Warnings Using more than one enema in 24 hours can be harmful. For rectal use only. Do not use for more than 3 days if you have kidney disease if you have heart problems if you are dehydrated when abdominal pain, nausea, or vomiting are present unless directed by a doctor Ask a doctor before using this product if you are 55 years of age or older are on a sodium-restricted diet have a sudden change in bowel habits lasting more than 2 weeks already used a laxative for more than 1 week Stop use and ask a doctor if you have rectal bleeding no bowel movement or no liquid comes out of the rectum after 30 minutes symptoms of dehydration [feeling thirsty, dizziness, vomiting, urinating less often than normal] These symptoms may indicate a serious condition.

Formulary and pricing (Philippines)

Government price references

PreparationPrice (PHP)UnitType
Monobasic Sodium Phosphate, Dibasic Sodium Phosphate 19 g/ 7 g solution per 133 mL Bottle₱175.50–₱213.00Reference ₱205.00per bottleDPRI procurement range

Range = lowest-highest procurement price (highest usable only in GIDA areas); reference_price = 2021 DPRI ceiling (median)

These are government procurement and reimbursement references, not retail prices. Sources:

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. U.S. Food and Drug Administration. Fleet · C.B. Fleet Company, Inc. [US FDA-approved label, version 12, November 20, 2025]. Via DailyMed/openFDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c1677d70-203b-493e-88f0-815a66133f1d
  2. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
  3. DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .